ArticleCancers2023

Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy.

Dung-Tsa Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.